Skip to main content
. 2017 Sep 30;8(70):114685–114697. doi: 10.18632/oncotarget.21425

Table 1. Patients characteristics and EGFR mutation status.

Variables No. EGFR status wt / mut (%) P-value
Age (y)
 ≤70 44 28 / 16 (63.6% / 36.4%) 0.59
 >70 39 27 / 12 (69.2% / 30.8%)
Smoking history
 Never smoker 15 4 / 11 (26.7% / 73.3%) <0.0003
 Smokers 68 51 / 17 (75.0% / 25.0%)
  ≤30 pack-years (15) 5 / 10 (33.3% / 66.7%)
  >30 pack-years (48) 41 / 7 (85.4% / 14.6%)
  unknown (5) 5 / 0 (100% / 0%)
Disease stage
 Stage I 52 (45*) 35 / 17 (67.3% / 32.7%) 0.96
 Stage II 20 (13*) 13 / 7 (65.0% / 35.0%)
 Stage III 11 (10*) 7/ 4 (63.6% / 36.4%)

* indicates the number of smoker patients.